NatWest Group plc (LON:NWG – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 390.02 ($5.06) and last traded at GBX 385.10 ($4.99), with a volume of 53687746 shares. The stock had previously closed at GBX 375.30 ($4.87).
Wall Street Analyst Weigh In
NWG has been the topic of a number of research reports. Citigroup reiterated a “buy” rating on shares of NatWest Group in a report on Monday, September 2nd. Berenberg Bank restated a “buy” rating and issued a GBX 415 ($5.38) price objective on shares of NatWest Group in a report on Wednesday, August 21st. Finally, JPMorgan Chase & Co. raised their price objective on shares of NatWest Group from GBX 370 ($4.80) to GBX 420 ($5.45) and gave the company an “overweight” rating in a report on Monday, July 29th. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 347.50 ($4.51).
Get Our Latest Research Report on NatWest Group
NatWest Group Stock Performance
Insiders Place Their Bets
In other NatWest Group news, insider Yasmin Jetha acquired 842 shares of the stock in a transaction on Tuesday, October 1st. The shares were bought at an average cost of GBX 344 ($4.46) per share, with a total value of £2,896.48 ($3,756.30). 16.15% of the stock is currently owned by insiders.
About NatWest Group
NatWest Group plc, together with its subsidiaries, provides banking and financial products and services to personal, commercial, corporate, and institutional customers in the United Kingdom and internationally. It operates through Retail Banking, Private Banking, and Commercial & Institutional segments.
See Also
- Five stocks we like better than NatWest Group
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Intel: Is Now the Time to Be Brave?
- ETF Screener: Uses and Step-by-Step Guide
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is MarketRank™? How to Use it
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for NatWest Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NatWest Group and related companies with MarketBeat.com's FREE daily email newsletter.